Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency

Immunosuppressive agents are the standard therapeutic approach for immune thrombocy-topenia (ITP). Their prolonged use may increase the risk of infectious complications, particularly when the patient is already at higher infectious risk. In this setting, the use of drugs with a mechanism of action a...

Descripción completa

Detalles Bibliográficos
Autores principales: Palandri, Francesca, Polverelli, Nicola, Lifrieri, Francesca, Catani, Lucia, Giannini, Maria Benedetta, Baccarani, Michele, Vianelli, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401131/
https://www.ncbi.nlm.nih.gov/pubmed/22826792
http://dx.doi.org/10.4081/hr.2012.e10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401131/
https://www.ncbi.nlm.nih.gov/pubmed/22826792
http://dx.doi.org/10.4081/hr.2012.e10

Ejemplares similares